An independent research guide, not a government site. No fees. Every official claim is free to file. How it works

Money Owed To Me

Twist Bioscience securities settlement

Class-action settlement8 days left to fileDeadline November 17, 2026

Class-action settlement. Claim deadline November 17, 2026. Possible amount: Documented losses, from a $17.05M fund, not guaranteed. Account or service history may be required. Filing on the official site is free.

When the money moves

What the official materials say about the payment schedule for this settlement, and what the administrator has published since. Every figure below is linked to the page it was read from.

Status
Payments have not started

Expected

The notice says payments follow the court's approval of the settlement and of the plan of allocation at the November 18, 2026 hearing, and the resolution of any appeals; it gives no payment date.

Read off the official notice, in its own words. These dates slip — an appeal can move a distribution by a year or more — so treat it as the administrator's plan rather than a schedule.

Source: the official notice

Who may be eligible

Twist Bioscience has agreed to a $17,050,000 cash settlement of a securities class action brought on behalf of people who bought or otherwise acquired its common stock between December 20, 2018 and November 15, 2022, including shares traceable to the December 2, 2020 secondary offering. If you held TWST in that window you may be eligible, but the administrator decides every claim and the proof of claim has to reach it by November 17, 2026 with broker confirmations or account statements for the trades. The site puts the gross recovery at about $0.31 a share before court-approved fees and expenses. Filing on the official settlement site is free, and the court considers final approval on November 18, 2026.

The eligibility period on the official materials is December 20, 2018 – November 15, 2022. The notice states no state limit, so it is usually nationwide. Covered: Twist Bioscience Corporation common stock (TWST).

Only the official administrator or agency decides who is eligible. Read the official notice before filing, and file only if you believe you meet its criteria.

How much it may pay

Documented losses, from a $17.05M fund. Every figure here is an estimate from public materials, not a guarantee: many settlements pay pro rata or only after a claims review, so final amounts commonly land well below the advertised maximum.

The site puts the gross recovery at about $0.31 a share before the deductions the court approves, which on a settlement this size typically take a quarter to a third of the fund, so the figure a claimant actually sees is lower. Shares are worked out from each claimant's recognised loss under the plan of allocation, so two people who bought the same number of shares on different dates can be paid very differently. The proof of claim asks for broker confirmations or account statements covering the trades. Figures here are estimates, not guarantees.

What the deadline is

The claim deadline is November 17, 2026.

The deadline to opt out or object is October 7, 2026.

The court's fairness hearing is set for November 18, 2026; payments do not go out until the settlement is finally approved and any appeals are resolved.

The notice says payments follow the court's approval of the settlement and of the plan of allocation at the November 18, 2026 hearing, and the resolution of any appeals; it gives no payment date.

What proof is needed

Account or service history may be required.

The official claim form states exactly what it accepts; gather it before you start.

How to file for free

Open the official claim page on this page, run by Simpluris (Twist Securities Settlement, case TPC2), read the criteria, and file there if you believe you meet them. Filing is free: official claims never carry a fee, and this site never files on anyone's behalf.

Never give a Social Security number, bank login or card number to a site that is not the official administrator or agency page.

Official claim page

Facts from the official materials

Status
Open
Type
Class-action settlement
Category
Banking and finance
Defendant / company
Twist Bioscience Corporation
Administrator
Simpluris (Twist Securities Settlement, case TPC2)
States
See official notice (often nationwide)
Source confidence
high
Last verified
October 26, 2026

Peters v. Twist Bioscience Corporation, et al. · 5:22-cv-08168-EKL · U.S. District Court, Northern District of California, San Jose Division

Eligibility questions

These questions help you decide whether to read the official notice. They are not a legal determination.

Did you buy or otherwise acquire Twist Bioscience (TWST) common stock between December 20, 2018 and November 15, 2022?
Do you still have broker confirmations or account statements covering those TWST trades?

The proof of claim asks for documentation of each purchase, sale and holding in the period.

Were you an officer or director of Twist Bioscience during the class period?

Securities settlements routinely exclude them from the class.

Track this record

Related records

Records that share a company, category, or subject with this one. Closed ones are marked; filing on the official site is free for the rest.

All open banking and finance records

Want to compare more than this one record? Check your eligibility across every open record.